Co-alteration of EGFR mutation and ALK rearrangement in non-small cell lung cancer: Case series

RATIONALE: Current guidelines for advanced non-small cell lung cancer (NSCLC) recommend the use of targeted agents for specific driver genes after confirming genetic alterations. Although epidermal growth factor receptor (EGFR) mutation and anaplastic lymphoma kinase (ALK) rearrangement are usually...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hong-Joon, Kho, Bo Gun, Kim, Min-Seok, Park, Ha Young, Kim, Tae-Ok, Kim, Yu-Il, Lim, Sung-Chul, Park, Cheol-Kyu, Kim, Young-Chul, Choi, Yoo-Duk, Oh, In-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831261/
https://www.ncbi.nlm.nih.gov/pubmed/30817606
http://dx.doi.org/10.1097/MD.0000000000014699

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831261/
https://www.ncbi.nlm.nih.gov/pubmed/30817606
http://dx.doi.org/10.1097/MD.0000000000014699

Ejemplares similares